Understanding the Difference Between Tirzepatide (Mounjaro) and Semaglutide (Wegovy/Ozempic)

GLP-1 and GIP Analogues for Weight Loss:

Semaglutide (Wegovy/Ozempic) and Tirzepatide (Mounjaro) are weekly injectable medications used for effective weight loss, especially when diet and exercise alone haven’t worked. These drugs mimic gut hormones — GLP-1 and GIP — which help regulate appetite, digestion, and blood sugar.

  • Semaglutide targets GLP-1 only, reducing hunger and slowing digestion, with around 15% average weight loss.

  • Tirzepatide targets both GLP-1 and GIP, offering stronger effects on appetite and metabolism, with up to 20%+ weight loss in trials.

Key Differences:

  • Tirzepatide offers more potent weight loss.

  • Both are weekly injections.

  • Side effects include nausea and digestive issues, with Tirzepatide potentially causing slightly more.

Niva Medical Clinic provides personalised, medically supervised weight loss programmes — unlike generic online services — with in-person assessments, GP monitoring, and lifestyle support. They serve patients across North West London and Hertfordshire.

Share this:

Facebook
Twitter
LinkedIn

Recent Posts

Visa and Pre Employment Medicals, Taxi/DVLA Medicals and Other Medical Form Completion at Niva Medical Clinic

Read More

Hay Fever Symptoms, Management and Pollen Avoidance Advice

Read More

Preventative healthcare

Why Preventative Healthcare Is the Future of Medicine in the UK

Healthcare in the UK is entering a period of necessary transformation. For many years, the system has been structured primarily around diagnosing and treating illness after it develops. While this approach remains essential, it is no longer sufficient on its own. Increasing demand, an ageing population, and the rising prevalence of long-term conditions have made it clear that a more proactive model is required.

Read More